Eli Lilly & Co. is stepping up its fight against a booming black market for retatrutide, an experimental drug that the company is counting on to expand its crucial weight-loss franchise. For almost two years, Lilly has been warning consumers not to take knockoff versions of the shot that…This story appeared on fortune.com , 2026-08-12 14:59:58.